Together with cells from the innate and adaptive immune systems and cytokines (e.g., tumor necrosis factor alpha [TNFα] and interleukin [IL]-6), leptin can generate a pro-inflammatory stage in the tumor microenvironment. This evidence concerns the gene LEP and neoplasm.